國內 BMO Capital上调Alnylam Pharmaceuticals目标价，Zilebesiran潜力获看好 Editorial 10 9 月, 2025 近日，BMO Capital Marke... Read MoreRead more about BMO Capital上调Alnylam Pharmaceuticals目标价，Zilebesiran潜力获看好
國內 BMO Capital上调Alnylam Pharmaceuticals目标价，Zilebesiran前景受青睐 Editorial 9 9 月, 2025 近期，BMO Capital Marke... Read MoreRead more about BMO Capital上调Alnylam Pharmaceuticals目标价，Zilebesiran前景受青睐
